{"id":1849,"date":"2018-12-31T00:00:38","date_gmt":"2018-12-30T17:00:38","guid":{"rendered":"https:\/\/www.hivnat.org\/en\/?p=1849"},"modified":"2022-03-30T10:07:17","modified_gmt":"2022-03-30T03:07:17","slug":"a-phase-iiib-randomized-open-label-study-of-the-safety-and-efficacy-of-dolutegravir-abacavir-lamivudine-once-daily-compared-to-atazanavir-and-ritonavir-plus-tenofovir-emtricitabine-once-daily-in-hiv","status":"publish","type":"post","link":"https:\/\/www.hivnat.org\/en\/studies\/1849\/","title":{"rendered":"A phase 3b, randomized, open-label study of the safety and efficacy of Dolutegravir\/Abacavir\/Lamivudine once daily compared to Atazanavir and Ritonavir plus Tenofovir\/Emtricitabine once daily in HIV-1 infected antiretroviral therapy na\u00efve women"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">This study is designed to demonstrate the non-inferior antiviral activity of DTG\/ABC\/3TC fixed dose combination (FDC) once daily (OD) compared to atazanavir plus ritonavir (ATV+RTV) and tenofovir disoproxil fumarate\/emtricitabine fixed dose combination (TDF\/FTC FDC) OD in HIV-1 infected, ART-na\u00efve women over 48 weeks. This study will also characterize the safety and tolerability of DTG\/ABC\/3TC FDC compared to ATV+RTV+TDF\/FTC FDC. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>\t\t\t\tThis study is designed to demonstrate the non-inferior antiviral activity of DTG\/ABC\/3TC fixed dose combination (FDC) once daily (OD) compared to atazanavir plus ritonavir (ATV+RTV) and tenofovir disoproxil fumarate\/emtricitabine fixed dose combination (TDF\/FTC FDC) OD in HIV-1 infected, ART-na\u00efve women over 48 weeks.\t\t<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[],"class_list":["post-1849","post","type-post","status-publish","format-standard","hentry","category-studies"],"_links":{"self":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/1849","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/comments?post=1849"}],"version-history":[{"count":1,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/1849\/revisions"}],"predecessor-version":[{"id":3350,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/1849\/revisions\/3350"}],"wp:attachment":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/media?parent=1849"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/categories?post=1849"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/tags?post=1849"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}